Pfizer

FDA Authorizes Second COVID Booster For Those 50 And Older

This fourth coronavirus vaccine dose would be optional, and federal health officials aren't currently recommending it for everyone in this age group.
By 

Pfizer Expected To Seek Approval For Additional Booster Shot For Seniors

It would add a fourth dose to the vaccination regimen in an effort to provide maximum protection to the over-65 population.
By Zeke Miller, AP

Pfizer CEO Says Fourth COVID Vaccine Dose 'Is Necessary'

Pharmaceutical head Albert Bourla said it is preparing to submit data to the FDA that would show the effectiveness of receiving a second booster shot.
By 

Pfizer Shots Protect Kids From Severe COVID Even In Omicron

The new data comes a day after a study of New York children suggested the vaccine may not be as effective in 5- to 11-year-olds as in older kids.
By Lauran Neergaard, AP

Pfizer Postpones Request To Give COVID Vaccines To Kids Under 5

The company said it will wait until it has more data on a third dose.
By 

Pfizer Asks FDA To Approve COVID-19 Vaccine For Kids Under 5

The nation’s 19 million children under five are the only group not yet eligible for vaccination against the coronavirus.
By Lauran Neergaard and Matthew Perrone, AP

Pfizer Begins Clinical Trial For Omicron-Targeting Vaccine

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
By LAURAN NEERGAARD, AP

Fauci: COVID Vaccines For Kids Under 5 Could Be Approved By Next Month

But that depends on data and the FDA, he cautioned.
By 

FDA Approves COVID-19 Booster Shots For 12- To 15-Year-Olds

The agency also shortened the amount of time that people 12 and older need to wait before receiving a booster shot, from six months to five.
By 

CDC Recommends Cutting 10-Day COVID Isolation Period In Half

U.S. officials say the guidance is due to growing evidence that those with COVID-19 are most infectious in the two days before and three days after symptoms develop.
By Mike Stobbe, AP